Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Wong

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Cell Stem Cell|May 29, 2020
The Rational Development of CD133-Targeting Immunotherapies for GlioblastomaParvez Vora, Chitra Venugopal, Sabra Khalid Salim, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 <sup>+</sup> T cell responsesJillian M Jespersen J, Lia Avanesyan, Jean Publicover, et al.
Science Translational Medicine|April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responsesJillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
Nature Communications|January 9, 2026
Timely bespoke phage-antibiotic combination to treat refractory Pseudomonas aeruginosa mediastinitis and vascular graft infectionShimin Jasmine Chung, Yang Liu, Shuhua Thong, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Cell Stem Cell|May 29, 2020
The Rational Development of CD133-Targeting Immunotherapies for GlioblastomaParvez Vora, Chitra Venugopal, Sabra Khalid Salim, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 <sup>+</sup> T cell responsesJillian M Jespersen J, Lia Avanesyan, Jean Publicover, et al.
Science Translational Medicine|April 29, 2026
Clinical cure of chronic hepatitis B is associated with priming and perpetuation of hepatic CD4<sup>+</sup> T cell responsesJillian M Jespersen, Lia Avanesyan, Jean Publicover, et al.
Nature Communications|January 9, 2026
Timely bespoke phage-antibiotic combination to treat refractory Pseudomonas aeruginosa mediastinitis and vascular graft infectionShimin Jasmine Chung, Yang Liu, Shuhua Thong, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
Pageof 9